glp 1 and eyes GLP-1 Drugs Ocular Disease: Between Neuroprotection and Risk Does GLP-1 Cause Eye Problems?

Table of Contents: What is GLP-1, and how does tirzepatide enhance fat loss compared to Ozempic

Hum Genet

Freetext Ianoi SL, Calbureanu-Popescu MX, Ianoi NG, Ungureanu Mohora I, Tutunaru CV, Neagoe CD

Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals Don Tracy, Associate Editor Avexitide has received Breakthrough Therapy Designation by the FDA for post-bariatric hypoglycemia, congenital hyperinsulinism, and more

Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse

282 In strips of human skeletal muscle, GLP-1 promoted glycogen synthesis and inhibited glycogen phosphorylase activity- comparable findings were generated with L6 myotubes treated with GLP-1, as insulin-stimulated glycogen synthesis was increased